Contract awardedAseptic compounding, specials and contract pharmaceutical manufacturing

Ardena makes T3S trial drug for Cardiff University's LIONNS-D2 Project

Cardiff University chose Ardena Holding NV to make T3S (triiodothyronine sulphate), a new drug, for a Phase 2b clinical trial.

The work is for the LIONNS-D2 Project in the university's School of Medicine. The drug is meant for hypothyroid patients whose particular genetic variant changes how their bodies process thyroid hormone. Ardena produces the finished doses in blister packs as well as the trial medicine and its active ingredient, all to GMP standards. The drug's synthesis route is already validated, with preclinical and toxicology data behind it.

The contract was awarded directly and runs from November 2025 to January 2027. No value was published.

Alert me to similar tenders

Contract ends January 2027

What
Aseptic compounding, specials and contract pharmaceutical manufacturing
Value
Not published
How it was bought
Direct
Dates and next
Nov 2025 to Jan 2027

How it was bought

2 official notices
  1. 23 Oct 2025Award noticeFind a Tender
  2. 24 Oct 2025Award noticeFind a Tender
  3. 6 Nov 2025Contract starts
  4. 31 Jan 2027Contract ends

Cardiff University has bought this 5 times since 2021

Last bought
Oct 2026
Typical length
10 months
Typical value
£212,473
Suppliers used
4
AwardedContractWon byValue
Oct 2026Locked2 monthsLocked£187,587
Sep 2026Locked1 yearLocked£212,473
Apr 2026Locked8 monthsLocked·
Oct 2025This purchase1 yearArdena Holding NV·
May 2021LockedLocked£571,000

Suppliers Cardiff University has used

SupplierContractsValue
Locked2£187,587
Locked1£571,000
Locked1£212,473
Ardena Holding NV Won this one1·
See the contracts and who won them

Figures to 21 November 2026

How it compares

With every aseptic compounding, specials and contract pharmaceutical manufacturing award since 2021

Half of awards fall between £89,225 and £1.21mMedian £250,114

Awards
79
Firms that won them
64
Median award
£250,114
of 69 with a value
Typical length
2 years
In Wales
5 awards

Ardena Holding NV ranks 24th of 64 firms for aseptic compounding, specials and contract pharmaceutical manufacturing awards since 2021.

RankFirmAwardsValue
1Locked7£36.6m
2Locked5£16.1m
3Locked4£16.8m
4Locked3£30.6m
4Locked3£1.75m
4Locked3£197,829
24Ardena Holding NV Won this one1·
See who wins this work

Aseptic compounding, specials and contract pharmaceutical manufacturing at other buyers

Cardiff University has awarded 485 contracts since 2021.

See Cardiff University's page
  • Ardena Holding NV has won 1 public contract since 2021.

1 aseptic compounding, specials and contract pharmaceutical manufacturing tender is open now

See it
More aseptic compounding, specials and contract pharmaceutical manufacturing contracts awarded in 2025